Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML loom.ly/6Jbo6Fo #clinicaltrialsandobservations #myeloidneoplasia

Another good news klaxon! 📢 The drug, zanubrutinib is now recommended for adults in England, with untreated (with criteria), relapsed or refractory chronic lymphocytic leukaemia. This means access to the drug is available across the UK! Details 👇 bloodcancer.org.uk/news/drug-zanu…